Scientists identify hundreds of drug candidates to treat COVID-19
A COVID-19 vaccine needs the public's trust – and it's risky to cut corners on clinical trials, as Russia is
U.S. inks $1.5 billion deal with Moderna for 100 million doses of COVID-19 vaccine
Philippines, Brazil Interested In Russian COVID-19 Vaccine; Australia Suffers Deadliest Day Yet: Live Updates
Mexico to trial China and U.S. Covid-19 vaccines, may produce some
Rapid Reviews: COVID-19 looks at neurological side effects of COVID-19, vaccines, and more
Russia first to approve Covid-19 vaccine
Mid-Market Update: S&P 500 eyes record on data and vaccine news, Oil rallies, Gold and dollar sink
Vaxart's (VXRT) Stock Will Surge 130% From Current Levels, Says Analyst
Certara adds to its COVID-19 toolkit with virtual trials module
COVID-19 Prevention Network launches two research studies evaluating monoclonal antibodies
Agtech to the rescue in a pandemic: adapting plant labs for human testing
Global coronavirus cases hit 20 million: Reuters tally
First patients in NIH ACTIV-3 clinical trial enroll in Dallas
With 160 Vaccine Candidates In Development, Goldman Expects An Economic Boom Once At Least One Is Approved By The End Of 2020
Bristol Myers Reports Significant Survival Improvement For Rare Lung Cancer
Fauci Warns COVID-19 Vaccine May Only Be "50% Or 60%" Effective
2 Top Coronavirus Stocks with Massive Upside Potential
Amarin’s Vascepa To Take Part In Covid-19 Study In Adults With Heart Disease
UPDATED: FDA hands out a quick OK for potential SMA blockbuster risdiplam, giving Genentech and Roche a chance to challenge rivals on the price
Intranasal vaccine platform has potential for more effective vaccines, fewer side effects
Pfizer to make Gilead’s COVID-19 treatment remdesivir
Wearable fitness devices deliver early warning of possible COVID-19 infection
How machine learning and artificial intelligence can drive clinical innovation
Pharma’s Apollo 13 moment
Lundbeck gets cold feet, axes schizophrenia drug trial
Fauci expects tens of millions of coronavirus vaccine doses at start of 2021
Novavax says COVID-19 vaccine could be approved by year-end
Policy - Coronavirus vs AMR
Moderna prices COVID-19 vaccine at $32-$37 per dose for smaller volume deals